Delivery Order SPE2DE24D0013-SPE2D626F102F
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $8,603.68 by the Defense Logistics Agency Medical Supply Chain on October 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, calls for diagnostic reagents and test kits for the GeneXpert platform, specifically for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Work will be performed in Sunnyvale, California,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $5,440 firm fixed-price delivery order (4569923610) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus—consistent with Cepheid's core competency in rapid molecular diagnostic testing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $10,914 on September 22, 2025, by the Defense Logistics Agency's Medical Supply Chain division under the Defense Department. The firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by October 6, 2025, and will be performed at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents procurement...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $4,080 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on November 10, 2025, with an ultimate completion date of November 18, 2025. The delivery order, designated 4569971783 and titled XPCOV2/FLU/RSV-10, procures diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $6,800 delivery order (4569923616) by the Defense Logistics Agency Medical Supply Chain on November 4, 2025, with an ultimate completion date of November 12, 2025. The contract is for XPCOV2/FLU/RSV-10 diagnostic products—molecular testing reagents and cartridges for detecting COVID-19, influenza, and respiratory syncytial virus on the GeneXpert diagnostic platform. This is a firm fixed-price delivery order with no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $8,976 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on October 29, 2025, with an ultimate completion date of November 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic reagents and test kits for detection of COVID-19, influenza, and respiratory syncytial virus. This award carries no set-aside designation and represents a...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $68,000 firm fixed-price delivery order (Contract No. 4569923609, XPCOV2/FLU/RSV-10) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, which carries no set-aside designation, is for diagnostic reagents and test kits related to COVID-19, influenza, and respiratory syncytial virus (RSV)...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F102FDelivery Order
Cepheid Inc. was awarded a $4,838.52 firm fixed-price delivery order (4569983524) by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with completion expected by November 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves molecular diagnostic testing reagents and assays for the GeneXpert diagnostic platform, specifically cartridges designed to detect COVID-19, influenza, and respiratory syncytial virus. The work will be performed at Cepheid's facility in Sunnyvale, California. No set-aside designation was applied to this award, reflecting Cepheid's competitive standing in the federal molecular diagnostics market. This delivery order is consistent with Cepheid's established role as a primary federal supplier of diagnostic solutions across multiple federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. The company maintains substantial indefinite delivery contracts with the VA, including a $32.8M contract with VISN 6 and a $6.7M contract with VISN 17, both extending through 2029–2030. These vehicles and accompanying delivery orders reflect the federal government's reliance on Cepheid's GeneXpert platform and associated molecular testing capabilities to support clinical laboratory operations and infectious disease testing requirements across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 11/12/25 |